Many
subtype-selective dopamine receptor ligands developed for
the D2–D4 family incorporate a 1-arylpiperazine-derived
primary recognition motif, which is connected to a lipophilic moiety
occupying an extended binding pocket (EBP) of the receptor via an
aliphatic linker of variable lengths. The evaluation of a novel group
of dopamine receptor ligands now showed that highly subtype-selective
ligands [up to K
i(D4.4) = 0.25
nM, D2L/D4.4 = 320, D3/D4.4 = 710 for APH199 (17)] can be obtained by choosing
a relatively large and conformationally flexible 1-benzyl-1-phenylsemicarbazide
substructure to fill the EBP. The novel chemotype APH199 (17) was found to act as a full agonist at the D4 receptor
showing significant bias toward G protein activation over β-arrestin
recruitment in comparison to quinpirole.
Radical carbofluorination reactions starting from arylhydrazines and nonactivated alkenes, in which the C−F bond is formed through the use of Selectfluor, can be improved through the addition of anisole. Because direct trapping products could be detected only in trace amounts, anisole does primarily act as a reversible scavenger for the highly reactive ammonium radical dication released from Selectfluor in the C−F bond‐forming step. As shown for three diverse substitution patterns, the main role of anisole is to prevent, or at least reduce, the undesired addition of the ammonium radical dication to the alkene, which in turn leads to an unfavorable consumption of the arylhydrazine‐derived precursors required for carbofluorination. Moreover, besides the remarkable polar effects in radical trapping, this study shows that the Selectfluor‐derived nitrogen‐centered radical dication may add directly to alkenes, which has not been described so far.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.